TABLE 4.

Microsatellite stability status in each tumor type classified by anatomical site or histology

Tumor type	All cases N = 26 237	MSI‐L/MSS N = 25 260	MSI‐H N = 977	Frequency of MSI‐H 3.72*
Upper urinary tract	18	15	3	16.67
Adrenal gland	26	23	3	11.54
Testis	22	20	2	9.09
Urachus	20	19	1	5.00
Appendix	41	39	2	4.88
Brain	26	25	1	3.85
Peritoneum	83	80	3	3.61
Skin	74	72	2	2.70
Pancreatic neuroendocrine tumor	43	42	1	2.33
Papilla vater/duodenal papilla	52	51	1	1.92
Non‐small‐cell lung cancer	58	57	1	1.72

MSI‐H, microsatellite instability‐high; MSI‐L, microsatellite instability‐low; MSS, microsatellite stable.

*The frequency of MSI‐H in all the samples.